Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

41.94
Delayed Data
As of 3:59pm ET
 -1.75 / -4.01%
Today’s Change
37.59
Today|||52-Week Range
74.66
-22.43%
Year-to-Date

Today’s Trading

Previous close43.69
Today’s open43.40
Day’s range41.58 - 43.50
Volume5,547,625
Average volume (3 months)5,765,724
Market cap$22.2B
Dividend yield--
Data as of 3:59pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+14.23%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+21.91%
P/E ratio18.1
Price/Sales2.84
Price/Book2.20

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-1.10-2.28%
VRTXVertex Pharmaceutica...-1.53-1.86%
PRGOPerrigo Company PLC-0.91-0.94%
BMRNBiomarin Pharmaceuti...-2.95-3.47%
Data as of 4:02pm ET, 05/04/2016

Financials

Last reporting dateMay 4, 2016
EPS forecast (this quarter)$0.76
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts

Partner Offers

Search for Jobs